92 related articles for article (PubMed ID: 26179662)
1. Effect of targeted ovarian cancer therapy using amniotic fluid mesenchymal stem cells transfected with enhanced green fluorescent protein-human interleukin-2 in vivo.
You Q; Yao Y; Zhang Y; Fu S; Du M; Zhang G
Mol Med Rep; 2015 Oct; 12(4):4859-66. PubMed ID: 26179662
[TBL] [Abstract][Full Text] [Related]
2. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.
Bitsika V; Roubelakis MG; Zagoura D; Trohatou O; Makridakis M; Pappa KI; Marini FC; Vlahou A; Anagnou NP
Stem Cells Dev; 2012 May; 21(7):1097-111. PubMed ID: 21988169
[TBL] [Abstract][Full Text] [Related]
3. Characterization, GFP gene Nucleofection, and allotransplantation in injured tendons of ovine amniotic fluid-derived stem cells.
Colosimo A; Curini V; Russo V; Mauro A; Bernabò N; Marchisio M; Alfonsi M; Muttini A; Mattioli M; Barboni B
Cell Transplant; 2013; 22(1):99-117. PubMed ID: 22507078
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of human amniotic fluid mesenchymal stem cells and their tropism to human ovarian cancer.
Li L; Wang D; Zhou J; Cheng Y; Liang T; Zhang G
PLoS One; 2015; 10(4):e0123350. PubMed ID: 25880317
[TBL] [Abstract][Full Text] [Related]
5. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
6. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
7. Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice.
Hu W; Wang J; He X; Zhang H; Yu F; Jiang L; Chen D; Chen J; Dou J
Biotechnol Appl Biochem; 2011; 58(6):397-404. PubMed ID: 22172102
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure.
Zagoura DS; Roubelakis MG; Bitsika V; Trohatou O; Pappa KI; Kapelouzou A; Antsaklis A; Anagnou NP
Gut; 2012 Jun; 61(6):894-906. PubMed ID: 21997562
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma.
Gao P; Ding Q; Wu Z; Jiang H; Fang Z
Cancer Lett; 2010 Apr; 290(2):157-66. PubMed ID: 19786319
[TBL] [Abstract][Full Text] [Related]
10. Autologous transplantation of amniotic fluid-derived mesenchymal stem cells into sheep fetuses.
Shaw SW; Bollini S; Nader KA; Gastaldello A; Mehta V; Filppi E; Cananzi M; Gaspar HB; Qasim W; De Coppi P; David AL
Cell Transplant; 2011; 20(7):1015-31. PubMed ID: 21092404
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer.
Kikuchi H; Yagi H; Hasegawa H; Ishii Y; Okabayashi K; Tsuruta M; Hoshino G; Takayanagi A; Kitagawa Y
J Surg Res; 2014 Jul; 190(1):134-43. PubMed ID: 24679698
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Mediated Mesenchymal Stem Cells Transfection as a Targeted Cancer Therapy Platform.
Haber T; Baruch L; Machluf M
Sci Rep; 2017 Feb; 7():42046. PubMed ID: 28169315
[TBL] [Abstract][Full Text] [Related]
13. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
[TBL] [Abstract][Full Text] [Related]
14. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
[TBL] [Abstract][Full Text] [Related]
15. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191
[TBL] [Abstract][Full Text] [Related]
16. Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer.
Yin PT; Shah S; Pasquale NJ; Garbuzenko OB; Minko T; Lee KB
Biomaterials; 2016 Mar; 81():46-57. PubMed ID: 26720500
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of bone formation by genetically engineered human umbilical cord-derived mesenchymal stem cells expressing osterix.
Wang B; Huang S; Pan L; Jia S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Oct; 116(4):e221-9. PubMed ID: 22819334
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
[TBL] [Abstract][Full Text] [Related]
19. Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells.
Yoon BS; Moon JH; Jun EK; Kim J; Maeng I; Kim JS; Lee JH; Baik CS; Kim A; Cho KS; Lee JH; Lee HH; Whang KY; You S
Stem Cells Dev; 2010 Jun; 19(6):887-902. PubMed ID: 19686050
[TBL] [Abstract][Full Text] [Related]
20. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
Liu YL; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
